Advertisement
Advertisement
Bio-Gene Technology Reports Positive Flavocide® Results at Tick-borne Disease Conference
PremiumCompany AnnouncementsBio-Gene Technology Reports Positive Flavocide® Results at Tick-borne Disease Conference
2M ago
Bio-Gene’s Flavocide Shows Promising Results Against Lyme Disease Ticks
Premium
Company Announcements
Bio-Gene’s Flavocide Shows Promising Results Against Lyme Disease Ticks
2M ago
Bio-Gene Technology Ltd. Strengthens Governance Framework
Premium
Company Announcements
Bio-Gene Technology Ltd. Strengthens Governance Framework
3M ago
Bio-Gene Technology Announces Director’s Increased Shareholding
PremiumCompany AnnouncementsBio-Gene Technology Announces Director’s Increased Shareholding
4M ago
Bio-Gene Technology Updates Director’s Shareholdings
Premium
Company Announcements
Bio-Gene Technology Updates Director’s Shareholdings
4M ago
Bio-Gene Technology Announces Director’s Interest Change
Premium
Company Announcements
Bio-Gene Technology Announces Director’s Interest Change
4M ago
Bio-Gene Technology Ltd Announces Quotation of New Securities on ASX
PremiumCompany AnnouncementsBio-Gene Technology Ltd Announces Quotation of New Securities on ASX
5M ago
Bio-Gene Technology Raises $2.45 Million Through Share Purchase Plan
Premium
Company Announcements
Bio-Gene Technology Raises $2.45 Million Through Share Purchase Plan
6M ago
Alina Barlow Acquires Substantial Stake in Bio-Gene Technology Ltd.
Premium
Company Announcements
Alina Barlow Acquires Substantial Stake in Bio-Gene Technology Ltd.
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100